Last updated 2026-06-18
- Acquired by Frutarom, Jan 2018
- Raised $12.9M funding round, Aug 2017
- Raised $10M funding round, Jan 2012
Total raised
$100.4M
Last: 2017-08
Stage
Acquired
Founded
1998
Headcount
85
HQ
Migdal HaEmek, Israel
Sector
Health Tech & Life Sciences
About
Enzymotec is a biotechnology company that develops and produces biofunctional ingredients designed to address the health needs of everyone from babies to senior citizens. Enzymotecs nutrition and pharmaceutical business segments leverage the companys expertise in lipids. The nutrition segment manufactures lipid-based ingredients for use in products such as infant formula, nutritional supplements, and other dietary needs. The companys VAYA pharmaceutical segment makes and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases, including for the cardiovascular and neurological markets. Enzymotec is a fully owned subsidiary of Frutarom.
Funding history · 5 rounds · $100.4M total
2017-08
$12.9M
2012-01
$10.0M
2009-02
2000-01
$1.0M
Q&A
- What is Enzymotec's primary business?
- Enzymotec is a biotechnology company focused on developing and producing lipid-based biofunctional ingredients for health needs across all age groups, from infants to seniors. Their products are used in nutritional supplements, infant formula, and medical foods for various disorders.
- When was Enzymotec founded?
- Enzymotec was founded in March 1998.
- What is the current status of Enzymotec?
- Enzymotec was acquired by Frutarom in January 2018 and is now a fully owned subsidiary.
- How much funding has Enzymotec raised in total?
- Enzymotec has raised a total of $100,400,000 across multiple funding rounds.
- Which investors participated in Enzymotec's 2012 funding round?
- In January 2012, TPY Capital participated in a funding round for Enzymotec.
- What is Enzymotec's employee count?
- Enzymotec has an employee count in the 51-200 range.
- Where is Enzymotec's headquarters located?
- Enzymotec's headquarters is located in Migdal HaEmek, North District, Israel.
- What are the main sectors Enzymotec operates in?
- Enzymotec primarily operates in the Health Tech & Life Sciences, Pharma & Medical Biotechnology, and Biomaterials & Tissue Engineering sectors.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C
Tags
seniorsadhdnutritionbiotechnologysupplementspharmaceuticalsbabiesfoodtechnovel-ingredientsfood-and-beveragepharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/411959 | |
| YouTube | youtube.com/channel/UCTXtDL_Ly0EbjVO9o76cDsA |
Identifiers & details
| Founded | 1998-3 |
|---|---|
| Employees (exact) | 85 |
| Offices | Morristown; Bentleigh; China |
| Status reason | Acquired (Inactive) by Frutarom on Jan 2018 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Frutarom 2018-01
Radar intelligence
Patents
| EPO | 49 |
|---|
Publications (Crossref)
| Works | 8 |
|---|